Details for New Drug Application (NDA): 017875
✉ Email this page to a colleague
The generic ingredient in LOESTRIN 21 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 017875
Tradename: | LOESTRIN 21 1.5/30 |
Applicant: | Teva Branded Pharm |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.03MG;1.5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Complete Access Available with Subscription